$0.9206
0.1926.14%
In chiusura: -
$0.6734
-0.25-26.85%
After hour: 7:59 PM EDT
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su GT Biopharma Inc (NASDAQ:GTBP) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 1.04M a 1.31M. Questo rappresenta il 12.37% delle azioni disponibili pubblicamente dell'azienda.
Sulla base del volume medio recente di 581.90K azioni scambiate al giorno, ci vorrebbero 2.25 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
1.31M
Vendite allo scoperto %
12.4%
Giorni di copertura
2.25
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
GTBP | GT Biopharma, Inc. Common Stoc | 10/31/2025 | 11/11/2025 | 12.37% | 10,595,929 | 1,310,410 | 581,898 | 2.25 | |
GTBP | GT Biopharma, Inc. Common Stoc | 10/15/2025 | 10/24/2025 | 29.71% | 3,517,296 | 1,044,888 | 7,583,718 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 09/30/2025 | 10/09/2025 | 6.94% | 3,517,296 | 244,248 | 539,761 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 09/15/2025 | 09/24/2025 | 8.52% | 3,517,296 | 299,507 | 714,421 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 08/29/2025 | 09/10/2025 | 5.20% | 3,517,296 | 183,043 | 147,981 | 1.24 | |
GTBP | GT Biopharma, Inc. Common Stoc | 08/15/2025 | 08/26/2025 | 7.42% | 3,517,296 | 260,999 | 75,152 | 3.47 | |
GTBP | GT Biopharma, Inc. Common Stoc | 07/31/2025 | 08/11/2025 | 8.73% | 3,232,789 | 282,275 | 79,147 | 3.57 | |
GTBP | GT Biopharma, Inc. Common Stoc | 07/15/2025 | 07/24/2025 | 8.46% | 3,232,789 | 273,519 | 140,458 | 1.95 | |
GTBP | GT Biopharma, Inc. Common Stoc | 06/30/2025 | 07/10/2025 | 9.55% | 3,232,789 | 308,730 | 83,081 | 3.72 | |
GTBP | GT Biopharma, Inc. Common Stoc | 06/13/2025 | 06/25/2025 | 7.08% | 3,107,789 | 220,120 | 68,291 | 3.22 | |
GTBP | GT Biopharma, Inc. Common Stoc | 05/30/2025 | 06/10/2025 | 5.96% | 2,546,102 | 151,779 | 156,013 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 05/15/2025 | 05/27/2025 | 1.43% | 2,546,102 | 36,519 | 6,293 | 5.8 | |
GTBP | GT Biopharma, Inc. Common Stoc | 04/30/2025 | 05/09/2025 | 1.55% | 2,496,102 | 38,658 | 29,074 | 1.33 | |
GTBP | GT Biopharma, Inc. Common Stoc | 04/15/2025 | 04/25/2025 | 2.03% | 2,496,102 | 50,641 | 16,981 | 2.98 | |
GTBP | GT Biopharma, Inc. Common Stoc | 03/31/2025 | 04/09/2025 | 2.90% | 2,496,102 | 72,301 | 28,773 | 2.51 | |
GTBP | GT Biopharma, Inc. Common Stoc | 03/14/2025 | 03/25/2025 | 3.77% | 2,496,102 | 94,195 | 49,501 | 1.9 | |
GTBP | GT Biopharma, Inc. Common Stoc | 02/28/2025 | 03/11/2025 | 11.47% | 2,182,367 | 250,247 | 3,019,222 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 02/14/2025 | 02/26/2025 | 8.45% | 2,182,367 | 184,328 | 22,935 | 8.04 | |
GTBP | GT Biopharma, Inc. Common Stoc | 01/31/2025 | 02/11/2025 | 9.01% | 2,182,367 | 196,523 | 46,621 | 4.22 | |
GTBP | GT Biopharma, Inc. Common Stoc | 01/15/2025 | 01/27/2025 | 8.56% | 2,182,367 | 186,909 | 484,507 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 12/31/2024 | 01/10/2025 | 4.12% | 2,182,367 | 89,991 | 2,014,282 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 12/13/2024 | 12/24/2024 | 0.63% | 2,182,367 | 13,718 | 29,871 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 11/29/2024 | 12/10/2024 | 0.51% | 2,182,367 | 11,069 | 18,323 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 11/15/2024 | 11/26/2024 | 0.89% | 2,182,367 | 19,411 | 23,708 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 10/31/2024 | 11/11/2024 | 0.81% | 2,182,367 | 17,725 | 31,388 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 10/15/2024 | 10/24/2024 | 0.48% | 2,182,367 | 10,375 | 13,577 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 09/30/2024 | 10/09/2024 | 0.23% | 2,182,367 | 5,017 | 15,333 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 09/13/2024 | 09/24/2024 | 0.36% | 2,182,367 | 7,760 | 7,654 | 1.01 | |
GTBP | GT Biopharma, Inc. Common Stoc | 08/30/2024 | 09/11/2024 | 0.43% | 2,182,367 | 9,282 | 8,252 | 1.12 | |
GTBP | GT Biopharma, Inc. Common Stoc | 08/15/2024 | 08/26/2024 | 0.88% | 2,182,367 | 19,294 | 12,110 | 1.59 | |
GTBP | GT Biopharma, Inc. Common Stoc | 07/31/2024 | 08/09/2024 | 0.80% | 2,104,690 | 16,838 | 11,426 | 1.47 | |
GTBP | GT Biopharma, Inc. Common Stoc | 07/15/2024 | 07/24/2024 | 0.78% | 2,104,690 | 16,466 | 22,931 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 06/28/2024 | 07/10/2024 | 2.04% | 2,104,690 | 43,008 | 95,201 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 06/14/2024 | 06/26/2024 | 1.52% | 2,104,690 | 32,015 | 60,372 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 05/31/2024 | 06/11/2024 | 1.71% | 2,104,690 | 36,013 | 7,723,533 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 05/15/2024 | 05/24/2024 | 0.20% | 1,364,690 | 2,735 | 6,781 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 04/30/2024 | 05/09/2024 | 0.45% | 1,328,672 | 5,973 | 6,152 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 04/15/2024 | 04/24/2024 | 0.25% | 1,328,670 | 3,264 | 8,384 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 03/28/2024 | 04/09/2024 | 0.66% | 1,328,670 | 8,746 | 21,549 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 03/15/2024 | 03/26/2024 | 0.37% | 1,328,670 | 4,898 | 14,952 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 02/29/2024 | 03/11/2024 | 0.43% | 1,328,670 | 5,691 | 9,066 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 02/15/2024 | 02/27/2024 | 0.25% | 1,328,670 | 3,256 | 22,951 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 01/31/2024 | 02/09/2024 | 1.81% | 1,328,670 | 24,083 | 127,355 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 01/12/2024 | 01/24/2024 | 0.15% | 39,860,126 | 58,832 | 142,201 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 12/29/2023 | 01/10/2024 | 0.06% | 39,860,126 | 23,533 | 183,212 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 12/15/2023 | 12/27/2023 | 0.17% | 39,860,126 | 66,761 | 156,154 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 11/30/2023 | 12/11/2023 | 0.15% | 39,860,126 | 58,226 | 91,701 | 1 | |
GTBP | GT Biopharma, Inc. Common Stoc | 11/15/2023 | 11/27/2023 | 0.39% | 39,860,126 | 154,318 | 147,007 | 1.05 |
In cerca di azioni più vendute allo scoperto?